摘要
目的 :评价万拉法新对躯体化障碍的疗效和副反应。方法 :对 68例躯体化障碍患者随机分为万拉法新组和多虑平组 ,治疗 6周 ,用汉密尔顿抑郁量表 (HAMD)、不良反应量表 (TESS)评定疗效和副反应。结果 :万拉法新与多虑平疗效相当 ,起效比多虑平快 ,没有严重的副反应。结论 :万拉法新治疗躯体化障碍疗效确切、起效快、副反应小。
Objective: To compare the efficacy and side effect of venlafax ine and doxepin in the treatment of somatization disorder. Method: 68 pa tients of Somati zation disorder were randomly assigned to venlafaxine group and doxepin group f or 6 weeks. Effects and side reactions were evaluated with HAMD and TESS before and after treatment. Results: The therapeutic efficacy in venlaf axine group was similar to that in doxepin. The efficacy in venlafaxine group went out faster i n beginning, venlafaxine had fewer side effects. Conclusion: Venl afaxine is effec five in the treatment of somatization disorder and produces fewer side effects.
出处
《中国民康医学》
2003年第10期590-590,594,共2页
Medical Journal of Chinese People’s Health
